Related Experiment Videos
Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53
1Department of Clinical Research and Medical Oncology/Hematology, University and Inselspital, Berne, Switzerland.
Cell Death and Differentiation
|December 26, 2001
Summary
The tumor suppressor p53 is often inactivated in cancer. Researchers identified human Delta Np73, which blocks p53 function and may contribute to tumor development.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Tumor suppressor p53 inactivation is common in cancer.
- p53 regulates cell cycle arrest and apoptosis in response to genotoxic stress.
- p73 protein shares structural and functional similarities with p53.
Purpose of the Study:
- To clone and characterize human Delta Np73 isoforms.
- To investigate the regulation of Delta Np73 by p53.
- To explore the role of Delta Np73 in carcinogenesis.
Main Methods:
- Cloning and characterization of human Delta Np73.
- Analysis of Delta Np73 regulation by p53 and p73 isoforms.
- Investigation of Delta Np73's effect on p53 and TAp73 function.
Main Results:
- Human Delta Np73 lacks the transactivation domain and is regulated by a separate promoter.
- Delta Np73 inhibits the transactivation activity and apoptosis-inducing functions of p53 and TAp73.
- Delta Np73 expression is upregulated by p53 and TA isoforms, forming a feedback loop.
Conclusions:
- Delta Np73 acts as a negative regulator of p53 and TAp73.
- The feedback loop involving Delta Np73 finely tunes p53 and TAp73 activity.
- Increased Delta Np73 expression, by inactivating p53, may play a role in tumorogenesis.